Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|April 1, 1999
A phase I study of paclitaxel for mobilization of peripheral blood progenitor cellsB A Burtness, A Psyrri, M Rose, et al.
British Journal of Cancer|August 14, 2014
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trialH Cheng, K Ballman, M Vassilakopoulou, et al.
Breast Cancer Research and Treatment|May 18, 2020
ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancerA Koumarianou, P Makrantonakis, F Zagouri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-upA Psyrri, M Kwong, S DiStasio, et al.
ESMO Open|January 10, 2021
Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapyM Ganzinelli, H Linardou, M F Alvisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)A Bamias, U Dafni, A Karadimou, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancerE Fountzilas, J Souglakos, J Alafis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 studyA Psyrri, C Fortpied, G Koutsodontis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2023
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinomaN Gavrielatou, E Fortis, A Spathis, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group studyE Fountzilas, S Karageorgopoulou, G Karakatsoulis, et al.
Pageof 6